Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiao Ke
Institution:
Chengdu Kanghong Biotech Co., Ltd. (China)
Observed institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Chengdu Kanghong Biotech Co., Ltd. (China),
Huazhong University of Science and Technology
ORCID:
0000-0001-8142-4646
Observed ORCID:
0000-0001-8142-4646
OpenAlex ID:
A5103200249
Gut dysbiosis impairs hippocampal plasticity and behaviors by remodeling serum metabolome
2022
·
Guoqiang Liu
, Quntao Yu
, et al.
·
Gut Microbes
·
85
PDF
C1q/Tumor Necrosis Factor–Related Protein‐9 Is a Novel Vasculoprotective Cytokine That Restores High Glucose‐Suppressed Endothelial Progenitor Cell Functions by Activating the Endothelial Nitric Oxide Synthase
2024
·
Qingsong Hu
, Wan Qu
, et al.
·
Journal of the American Heart Association
·
4
PDF
Pharmacokinetics, safety and preliminary efficacy of conbercept eye drops for corneal neovascularization: Results from phase I/IIa studies
2026
·
Qi Shen
, Pei Shu
, et al.
·
British Journal of Clinical Pharmacology
Characterization of the conbercept gene localization in DHFR- amplified CHO cells using fluorescence in situ hybridization.
2017
·
Ming-lei Shi
, Wei-li Lai
, et al.
·
PubMed
Determination of polysorbate 20 content in fusion protein injection by fluorescence polarization
2014
·
Niu Dong-yun
, Lian Wei
, et al.
·
Zhongguo shengwuzhipinxue zazhi
Show more works
View as search
Works count:
5
Citation count:
89
H-index:
2
I10-index:
1
Year
Topic
Type